Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Outlook for the Nanotechnology In Cancer Treatment Market Heading Into 2029?
In recent times, we have observed a swift expansion in the market size of nanotechnology in cancer treatment. The forecast predicts a rise from $137.90 billion in 2024 to $159.09 billion in 2025, indicating a compound annual growth rate (CAGR) of 15.4%. The historic growth phase can be credited to a global increase in early cancer detection awareness, an upsurge in the prevalence of cancer, escalating investments in nanomedicine research and development, growing preference for minimally invasive procedures, and government’s increasing financial support for oncology nanotech studies.
The forecast for the nanotechnology market in cancer treatment indicates swift expansion in the coming years, expecting to reach $278.07 billion in 2029 with a 15.0% compound annual growth rate (CAGR). The anticipated growth over the forecast timeframe is attributed to the escalating demand for targeted cancer treatments, integration of nanotechnology into drug delivery systems, a deeper concentration on individualized oncology treatment, a rise in clinical trials for nano-enabled cancer drugs, and an increase in the adoption of nanotheranostics for cancer care. Key trends predicted include advancements in nanoparticle drug delivery systems, innovative cancer-specific nanocarriers, the incorporation of AI into nanotechnology for precise oncology, the invention of multi-functional nanodevices for diagnosis and treatment, and the spread of nanotheranostics into personalized healthcare.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27357&type=smp
Which Factors Are Pushing The Nanotechnology In Cancer Treatment Market Forward?
The expansion of the cancer treatment market through nanotechnology is anticipated due to the increasing need for targeted therapies. Targeted therapies are cancer treatments uniquely designed to pinpoint molecular markers or pathways that are crucial to the growth and advancement of tumors. The escalated requirement for these specific therapies can be attributed to their capability to not only accurately assault cancer cells but also limit the harm brought to healthy tissue and control potential side effects. By administering accurate drug delivery to cancer cells, nanotechnology enhances targeted therapies, which boosts their effectiveness while mitigating harm to healthy tissues. For example, the American Society of Gene & Cell Therapy (ASGCT), a professional organization based in the US, revealed in a report in July 2023 that by the end of the first quarter of 2023, there were 247 gene therapies in Phase II. This number experienced a 5% increase, reaching 260 by the conclusion of the second quarter in 2023. Consequently, the expanding need for targeted therapies is propelling the development of nanotechnology in the cancer treatment market.
Which Segment Held The Largest Share In The Nanotechnology In Cancer Treatment Market In 2025?
The nanotechnology in cancer treatment market covered in this report is segmented
1) By Nanotechnology Type: Liposomes, Dendrimers, Nanoparticles
2) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Combined Therapy Approaches, Surgery Assistance
3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Other Cancer Types
4) By Application: Targeted Drug Delivery, Photothermal Therapy, Radiation Therapy Enhancement, Diagnostics And Imaging, Gene Delivery Systems
5) By End-User: Hospitals, Research Institutions, Diagnostics Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs)
Subsegments:
1) By Liposomes: Conventional Liposomes, Stealth Liposomes, Cationic Liposomes, Immunoliposomes
2) By Dendrimers: Polyamidoamine Dendrimers, Polypropyleneimine Dendrimers, Peptide-Based Dendrimers, Carbosilane Dendrimers
3) By Nanoparticles: Gold Nanoparticles, Magnetic Nanoparticles, Polymeric Nanoparticles, Quantum Dots, Lipid Nanoparticles
How Are Key Trends Driving Expansion In The Nanotechnology In Cancer Treatment Industry?
Key players in the nanotechnology cancer treatment market are turning their focus to develop advanced solutions such as nano formulations for immunotherapy, with an aim to improve immune targeting and reduce negative effects in cancer patients. Nano formulation within immunotherapy leverages nanotechnology to deliver immunity-centric treatments directly to the target areas, enhancing precise treatment plans while boosting drug stability, bioavailability, and the activation of immune response. For example, in December 2023, Cello Therapeutics, an American biotech firm, introduced its broad-spectrum therapeutic cancer nano vaccine known as CE120, which received approval from the Food and Drug Administration. This significant breakthrough treatment is the first to use platelet membrane-coated nanoparticles to treat solid tumors clinically. CE120 merges targeted drug delivery with immune system activation, seeking to eradicate tumors and prevent their future return. Its unique nanotechnology framework heightens both the precision of the treatment and immune response. This achievement establishes CE120 as a ground-breaking nanomedicine in the cancer treatment domain.
Which Organizations Are Driving Progress In The Nanotechnology In Cancer Treatment Industry?
Major companies operating in the nanotechnology in cancer treatment market are Pfizer Inc., AstraZeneca PLC, Novartis AG, Amgen Inc., GE Healthcare Technologies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Arrowhead Pharmaceuticals Inc., Nanobiotix S.A., EnGeneIC Ltd., Nanospectra Biosciences Inc., Sona Nanotech Inc., CritiTech Inc., Immix Biopharma Inc., DNA Nanobots LLC, Nanovery Limited, CytImmune Sciences Inc., NanOlogy LLC, NanoApps Medical Inc., ARIZ Precision Medicine.
Get The Full Report Here:
Which Region Is Expected To Experience The Highest Growth In The Nanotechnology In Cancer Treatment Industry?
North America was the largest region in the nanotechnology in cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanotechnology in cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27357&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model